/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Risk Factors, Part II, Item 7, Management s Discussion and Analysis of Financial Condition and Results of Operations and in this Item 1. However, you should consult any further disclosures we may make on these or related topics in our reports on Form 8-K or Form 10-Q filed with the Securities and Exchange Commission ("SEC").
$19.07
$0.32 (-1.65%)
Live · 09:32 PM
Operating margin is thin at 5.60%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 0.8% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 74% versus the prior year, cash generation momentum has weakened. Net debt of $215M represents 25.8x FCF, leverage limits flexibility.
23.0x earnings, 21.7x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$739M
▼ -0.8% YoY
Net Income (TTM)
$27M
▼ -11.2% YoY
Op. Margin
6.87%
▲ +0.1pp YoY
ROIC
9.23%
▼ -0.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$29M
▼ -74.2% YoY
Op. Cash Flow (TTM)
$54M
▼ -34.2% YoY
Net Debt
$189M
Cash & Equiv.
$22M
5Y CAGR: +4.1%
5Y CAGR: -30.8%
Continue Research
SourceComputed from the 10-Q filed 10 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 11 Aug 2026. How this is calculated.
Price from market data, live as of 3 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.
At a P/E of 23.0 and a price-to-free-cash-flow of 21.7, Mistras Group (MG) trades above a two-stage DCF intrinsic value of about $11.15 per share, so at $19.07 the stock looks overvalued (41.6% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Mistras Group scores 54/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $11.15 per share for MG, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $8.36. At today's $19.07, that puts the stock about 41.6% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Mistras Group scores 54 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 6.9% operating margin and a 9.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. MG currently trades above its estimated intrinsic value and scores 54/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.